Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants

BACKGROUND: Patients with primary and secondary immunodeficiencies have shown an impaired humoral immune response to COVID-19 vaccination. It is therefore of paramount importance to investigate anti-SARS-CoV-2 antibody levels in plasma pools and in immunoglobulin (IgG) products used to treat these p...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Carolina, Diez, José María, Gajardo, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Poster Presentation Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203947/
http://dx.doi.org/10.1016/j.clim.2023.109538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203947/
http://dx.doi.org/10.1016/j.clim.2023.109538

Ejemplares similares